EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improving access to gene therapy for rare diseases

Thomas A Fox iD, Claire Booth iD

Disease Models & Mechanisms · 01.06.2024 · 17 (6)

DOI: 10.1242/dmm.050623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 19.04.2024. Verfasst von Thomas A Fox und 1 weiteren Autor:innen. Beteiligte Einrichtung: UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, United Kingdom. Hauptthemen laut MEDLINE: Rare Diseases, Genetic Therapy. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Effective gene therapy approaches have been developed for many rare diseases, including inborn errors of immunity and metabolism, haemoglobinopathies and inherited blindness. Despite successful pre-clinical and clinical results, these gene therapies are not widely available, primarily for non-medical reasons. Lack of commercial interest in therapies for ultra-rare diseases, costs of development and complex manufacturing processes required for advanced therapy medicinal products (ATMPs) are some of the main problems that are restricting access. The complexities and costs of navigating the regulatory environments in different jurisdictions for treatments that affect small numbers of patients is a problem unique to ATMPS for rare and ultra-rare diseases. In this Perspective, we outline some of the challenges and potential solutions that, we hope, will improve access to gene therapy for rare diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesGenetic TherapyHumans

Stichwörter der Autor:innen

Gene therapyInborn errors of immunityInborn errors of metabolismRare disease

Autor:innen und Institutionen

  • UCL Institute of Immunity and Transplantation, University College London, London, NW3 2PP, United Kingdom.
  • Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health, UCL, London WC1N 1EH, UK.

ORCID-Profile: Thomas A Fox, Claire Booth

Zitieren

APA

Fox, T. A., & Booth, C. (2024). Improving access to gene therapy for rare diseases. Disease Models & Mechanisms, 17(6). https://doi.org/10.1242/dmm.050623

Vancouver

Fox TA, Booth C. Improving access to gene therapy for rare diseases. Disease Models & Mechanisms. 2024;17(6). doi:10.1242/dmm.050623

BibTeX
@article{Fox2024,
  author = {Fox, Thomas A and Booth, Claire},
  title = {Improving access to gene therapy for rare diseases},
  journal = {Disease Models & Mechanisms},
  year = {2024},
  volume = {17},
  number = {6},
  doi = {10.1242/dmm.050623}
}
Kostenlos starten →